(Q37385588)
Statements
A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck (English)
Glen C MacDonald
Michèle Rasamoelisolo
Joycelyn Entwistle
Jeannick Cizeau
Denis Bosc
Wendy Cuthbert
Mark Kowalski
Maureen Spearman
6 February 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference